Global Androgen Replacement Therapy Market- Key Players
Major players operating in the global androgen replacement therapy market include include AbbVie, Inc., Bayer AG, Endo International plc, Lilly, Kyowa Kirin Co., Ltd, Novartis AG, Pfizer Inc, Clarus Therapeutics, Perrigo Company plc, Acerus Pharmaceuticals Corporation, Sawai Pharmaceutical Co.,Ltd, Dr. Reddy’s Laboratories Ltd, Sun Pharmaceutical Industries Ltd., and Simple Pharma.
Global Androgen Replacement Therapy Market: Key Developments
On June 1, 2023, Getlabs, Inc., a provider for at-home diagnostic collections, partnered with Fountain TRT, a provider of testosterone replacement therapy (TRT) for men, to offer convenient at-home hormone testing and treatment.
On April 3, 2023, the U.K. Department of Health and Social Care, announced the launch of a new scheme to expand access to cheaper Hormone Replacement Therapy (HRT) drugs. This initiative was introduced to cut cost burden for hormone replacement therapies in the U.K.
On May 10, 2023, FarmaKeio Pharmacy Network, a pharmaceutical outsourcing facility in the U.S., was granted a patent to produce testosterone and triamcinolone subcutaneous hormone pellets. The drug was introduced to provide a sustained release of testosterone and triamcinolone, allowing patients to enjoy the benefits of these hormones for extended periods of time.
Androgen Replacement Therapy Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients